Who are Centene's decision-makers?
Centene is led by Sarah M. London. Sellers should map decisions across the executive sponsor, business-unit owner, procurement, legal, security, compliance, finance, and operational stakeholders.
- CEO
- Sarah M. London
- CFO/key exec
- Drew Asher
- Founded
- 1984
- Employees
- 60,000+
- HQ
- St. Louis, MO
- Status
- NYSE: CNC
- Sarah M. LondonChief Executive OfficerCEO since 2022Leads Centene's government-program focus and operational reset.
- Drew AsherExecutive Vice President and Chief Financial OfficerCFO since 2021Finance leader for rate cycles, capital allocation, and public reporting.
- Susan SmithChief Operating OfficerSenior executive leadershipOperations leader focused on execution and member experience.
- Dr. Alice Hm ChenChief Health OfficerSenior executive leadershipClinical strategy and health-equity leader.
Who leads Centene?
Centene's leadership team combines enterprise healthcare operations, finance, clinical, product, technology, legal, and commercial roles. The CEO and CFO set capital priorities, while business-unit leaders decide which operational problems become funded initiatives.
Who actually makes buying decisions at Centene?
Buying decisions usually start with a business-unit sponsor, then move through procurement, finance, legal, data-security, compliance, privacy, and implementation owners. Clinical, reimbursement, or quality stakeholders become essential whenever the purchase touches patient care, regulated data, medical products, or payer/provider economics.
How is Centene organized as it scales?
Centene operates through business units tied to Medicaid, Marketplace, Medicare, and specialty/government services. That creates multiple entry points, but enterprise standards for security, compliance, contracting, and vendor management can still control the final approval path.
As of June 2026.Sources:Centene leadershipCentene annual reports
Centene — frequently asked questions
